Article History
Received: 25 September 2023
Revised: 13 November 2023
Accepted: 13 November 2023
First Online: 2 December 2023
Competing interests
: HdW is on the Board of Directors of PharmAla Biotech and consultant to Awakn Life Sciences and Gilgamesh Pharmaceuticals. These were unrelated to the present research. HM, RL, and IT report no conflicts.